Admelog logo

Profile

25% lower NHS list price vs Humalog cartridges and pre-filled pens and 15% lower NHS list price vs Humalog vials2

1:1 initial unit dosing* – available in the SoloSTAR® pen, cartridges and vials1

*Changes in strength, brand, type, species and/or method of manufacture may result in the need for a change in dosage. Transferring to a different insulin should be done under strict medical supervision.

Similar PK/PD profile (T1DM)3, efficacy, safety and tolerability profiles (T1DM and T2DM)4-5

    Abbreviations:
    DSN, diabetes specialist nurse; EU, European Union, NHS, National Health Service; PD, pharmacodynamic; PK, pharmacokinetic; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus; UK, United Kingdom.

    References:

    1. Admelog SmPC October 2021
    2. The NHS Dictionary of Medicines and Devices Admelog: solution for injection. Available at: https://services.nhsbsa.nhs.uk/dmd-browser/search/results?ampName=admelog&searchType=AMP&showInvalidItems=false&size=50 Last accessed: October 2021
    3. Kapitza C, et al. Diabetes Obes Metab. 2017;19(5):622–7.
    4. Garg SK, et al. Diabetes Technol Ther. 2017;19(9):516–26
    5. Derwahl K, et al. Diabetes Technol Ther. 2018;20(1):1–10.
    6. Garg SK, et al. Diabetes Technol Ther. 2017;19(9):516–26
    7. Derwahl K, et al. Diabetes Technol Ther. 2018;20(1):1–10.

Diabetes Stories

Watch peer-to-peer videos of payors and healthcare professionals sharing best practices of adopting a rapid acting insulin biosimilar.

Marcus Jones - Formulary pharmacist

Length: 03:43

In this video you can learn how Marcus Jones accelerated the adoption of a rapid acting biosimilar insulin in his local region and how he collaborated with clinical teams to make a positive start and switch.

Dr Duncan Browne - Consultant Endocrinologist

Length: 03:32

In this video you can learn why Duncan Browne decided to prescribe a rapid acting insulin biosimilar, how he aligned internally the local service to drive the adoption of this biosimilar in his local region and find out how the patient experience has been with this biosimilar.

Amanda Veall - Diabetes Specialist Nurse

Length: 04:16

In this video you can learn why Amanda Veall decided to prescribe a rapid acting insulin biosimilar, how she collaborated with clinical teams to drive the adoption of this biosimilar in her local region and find out how the patient experience has been with this biosimilar.

Start and Switch

Watch and download resources to support your rapid acting insulin adoption.

  • What is a biosimilar medicine?

    Length: 07:00

    Some healthcare professionals require an extra reassurance on biosimilars. Learn from Grace Vanterpool explain what a biosimilar insulin is, how it works and performs and why should the NHS use biosimilar insulin, to support you in making a positive adoption with Trurapi.

  • Admelog Leaflet

    An overview of the clinical evidence, price comparison of Admelog versus Humalog® and information on dosing and the different presentations available.

  • Formulary FAQ

    Factual and technical information about Admelog to support you with relevant documentation for local formulary applications.

  • Admelog Poster

    Pharmacists and other Healthcare Professionals can print this poster and put it in drug fridges to provide information about Admelog.

  • Diabetes Stories

    Length: 04:02

    Starting or switching to a rapid acting insulin biosimilar can raise some concerns from healthcare professionals and patients. Watch how a payor, an endocrinologist and a diabetes specialist nurse implemented a rapid acting biosimilar insulin in their local region and how they collaborated with clinical teams and patients to make a positive start and switch

Get in touch with the Diabetes Team

MAT-XU-2201545 (v1.0)
Date of Preparation: June 2022

MAT-GB-2105789 (v1.0)
Date of Preparation: June 2022